Tradestie Institutional Equity Comparison Engine

CTRE vs SBRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CTRE Overall Edge

CTRE Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CareTrust REIT, Inc (CTRE) driven by superior Valuation, Growth & Margin while SBRA counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CTRE trades at 22.3x Forward P/E with 66.2% operating margin (+33.2% YoY revenue) versus SBRA at 28.2x Forward P/E and 18.4% operating margin (+31.6% YoY). In options structure, CTRE sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro) against SBRA sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CTRE
CTRE 22.3x vs SBRA 28.2x Fwd P/E
Growth & Margin Winner CTRE
Op Margin 66.2% vs 18.4% ยท YoY +33.2% vs +31.6%
Momentum & Technical Winner SBRA
1Y +5.4% vs +9.3% ยท 52W Pos 33% vs 55%
Options & Structure Winner SBRA
CONSOLIDATION (10th %ile IV) vs CONSOLIDATION (6th %ile IV)
CTRE NYSE
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.66
-1.06% 1D
Market Cap $9.8B
1M Return +3.05%
1Y Return +5.39%
Forward P/E 22.3x
Unified AI Score
46.6 / 100 HOLD
Tech 42.0 Fund 45.0 Flow 57.0 Mom 50.0
SBRA NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.42
-0.1% 1D
Market Cap $5.4B
1M Return +5.58%
1Y Return +9.31%
Forward P/E 28.2x
Unified AI Score
56.4 / 100 HOLD
Tech 43.0 Fund 56.0 Flow 74.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CTRE +5.39% SBRA +9.31% Spread: +3.92 pp (SBRA Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CTRE Revenue SBRA Revenue CTRE Op. Margin SBRA Op. Margin Margin Edge
Q3 '25 $420M $760M 57.1% 31.3% CTRE
Q4 '25 $430M $850M 58.7% 30.5% CTRE
Q1 '26 $470M $890M 58.0% 30.8% CTRE
Q2 '26 $490M $940M 53.8% -13.6% CTRE
Q3 '26 $540M $1.00B 57.3% 25.6% CTRE

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CTRE (8) vs SBRA (2)
Institutional Metric CTRE SBRA Criterion Row Winner
Market Capitalization Scale $9.8B $5.4B Larger Scale CTRE
Trailing P/E Ratio Valuation 24.0x 76.2x Lower Multiple CTRE
Forward P/E Ratio Valuation 22.3x 28.2x Lower Multiple CTRE
Revenue Growth (YoY) Growth +33.2% +31.6% Higher Growth CTRE
Operating Margin (TTM) Profitability 66.2% 18.4% Higher Margin CTRE
Net Profit Margin Profitability 59.2% 7.7% Higher Margin CTRE
Return on Equity (ROE) Capital Efficiency 7.7% 2.5% Higher ROE CTRE
52-Week Range Position Momentum 33% ($35โ€“$44) 55% ($18โ€“$23) Stronger Trend SBRA
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 28% Vol -0.01ฮฒ ยท 31% Vol Lower Realized Risk CTRE
Unified Institutional Score Composite Signal 46.6 / 100 (HOLD) 56.4 / 100 (HOLD) Higher Composite SBRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CTRE vs SBRA Buy Guide
CTRE CONSOLIDATION
83d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live CTRE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SBRA CONSOLIDATION
79d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live SBRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CTRE nor SBRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.